Acurx Pharmaceuticals, Inc.
ACXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736243
No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Acurx Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 3 | 8 | +5 |
| Shares | 25.5K | 64.7K | +39.2K (+154.1%) |
| Value | $163.0K | $332.0K | +$169.0K (+103.7%) |
New holders (6)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 30,090 | $155.0K | 0.00% |
| BlackRock Inc. | 6,515 | $33.0K | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 4,000 | $21.0K | 0.00% |
| Advisor Group Holdings, Inc. | 3,000 | $15.0K | 0.00% |
| Semmax Financial Advisors Inc. | 1,263 | $6.00K | 0.00% |
| Wells Fargo & Company | 15 | $0 | 0.00% |
Sold out (1)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Parsons Capital Management Inc | 15,000 | $96.0K |